The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(−/−) and LDLr(−/−) Mice by a Mechanism That Includes Inflammatory Pathways

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) liraglutide and semaglutide reduce cardiovascular risk in type 2 diabetes patients. The mode of action is suggested to occur through modified atherosclerotic progression. In this study, both of the compounds significantly attenuated plaque les...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakipovski, Günaj, Rolin, Bidda, Nøhr, Jane, Klewe, Ib, Frederiksen, Klaus S., Augustin, Robert, Hecksher-Sørensen, Jacob, Ingvorsen, Camilla, Polex-Wolf, Joseph, Knudsen, Lotte Bjerre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314963/
https://www.ncbi.nlm.nih.gov/pubmed/30623143
http://dx.doi.org/10.1016/j.jacbts.2018.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314963/
https://www.ncbi.nlm.nih.gov/pubmed/30623143
http://dx.doi.org/10.1016/j.jacbts.2018.09.004

Ejemplares similares